These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 12497543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ganciclovir-resistant cytomegalovirus in organ transplant recipients.
    Limaye AP.
    Clin Infect Dis; 2002 Oct 01; 35(7):866-72. PubMed ID: 12228824
    [Abstract] [Full Text] [Related]

  • 3. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
    Mylonakis E, Kallas WM, Fishman JA.
    Clin Infect Dis; 2002 May 15; 34(10):1337-41. PubMed ID: 11981729
    [Abstract] [Full Text] [Related]

  • 4. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ, Zaas AK, Hanson KE, Palmer SM.
    J Heart Lung Transplant; 2007 Dec 15; 26(12):1286-92. PubMed ID: 18096480
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New developments in the management of cytomegalovirus infection after solid organ transplantation.
    Eid AJ, Razonable RR.
    Drugs; 2010 May 28; 70(8):965-81. PubMed ID: 20481654
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
    Shah T, Lai WK, Mutimer D.
    Transpl Infect Dis; 2005 Jun 28; 7(2):57-62. PubMed ID: 16150091
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
    Young PG, Rubin J, Angarone M, Flaherty J, Penugonda S, Stosor V, Ison MG.
    Transpl Infect Dis; 2016 Jun 28; 18(3):390-5. PubMed ID: 27037651
    [Abstract] [Full Text] [Related]

  • 11. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM, Scott GM, Naing Z, Glanville AR, Rawlinson WD.
    Transpl Infect Dis; 2011 Apr 28; 13(2):145-53. PubMed ID: 21070537
    [Abstract] [Full Text] [Related]

  • 12. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
    Puius YA, Snydman DR.
    Curr Opin Infect Dis; 2007 Aug 28; 20(4):419-24. PubMed ID: 17609603
    [Abstract] [Full Text] [Related]

  • 13. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N.
    Clin Infect Dis; 2001 Mar 01; 32(5):742-51. PubMed ID: 11229841
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients.
    Boivin G, Goyette N, Gilbert C, Humar A, Covington E.
    Transpl Infect Dis; 2005 Mar 01; 7(3-4):166-70. PubMed ID: 16390409
    [Abstract] [Full Text] [Related]

  • 16. Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients.
    Avery RK, Marty FM, Strasfeld L, Lee I, Arrieta A, Chou S, Tatarowicz W, Villano S.
    Transpl Infect Dis; 2010 Dec 01; 12(6):489-96. PubMed ID: 20682012
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Cytomegalovirus infection in transplant recipients].
    Gondo H.
    Nihon Rinsho; 1998 Jan 01; 56(1):173-8. PubMed ID: 9465685
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.